Pharmaceutical group specializing in producing high value-added pharmaceutical products, research and development, covers an area of about 100 mu, with international standards and automatic production lines and quality control center, has advanced scientific research center and production equipment, facing the global pharmaceutical manufacturers to provide products and technical services. Scope of business mainly includes pharmaceutical product customization production, research and development outsourcing services; Pharmaceutical raw material export and international registration.
Medicine division of the API production line, has nine production workshop, three auxiliary workshop, four subsidiaries and two subsidiary drug research institutions and eight management department office. Main products adopt international standards, production workshop according to GMP management, now has a variety of acceptance by FDA, at present the main products are benzene with organism, ammonia, cefotaxime sodium ampicillin sodium, cetirizine hydrochloride, nai pp alkali, indications, luo erythromycin, tartaric acid rivastigmine, bromine between benzene methyl ether, fumaric acid f ROM mott and so on six big series more than 800 varieties, annual production of more than 50000 tons. And with Marine research institute of Chinese academy of sciences, China ocean university, China agricultural university, shandong agricultural university and other colleges and universities jointly set up key product research and development laboratory, effective broke the traditional API products a single, low yield, serious pollution, the long-term use of production leads to water damage problem, the products sell well all over the country, and exported to the European Union, the United States, Japan and southeast Asia and other global more than 80 countries and regions, favored by customers welcome, by the customer as "really green API".
Medical department has brought together a group of business focused research experts and business backbone, average age 30 years old; Company long-term commitment to biocatalysis technology research and industrialization of platform construction, good at including pharmaceutical products in the field of organic synthesis and enzymatic synthesis, currently has independent innovation technology more than 10 invention patents, has successively for more than 50 Chinese and foreign pharmaceutical companies to provide products and technical support. Formed with diabetes drugs and drug hepatitis c as the leading product series, is now in the construction of drug GMP production base and a global sales network for the future development to provide strong power.
Pharmaceutical group always advocates insist on two-way drive technology and product strategy, implements the positive, flexible policy for the protection of intellectual property rights and adhere to the differentiation of product selection and research production and sales integration business model. In the process of drug manufacturing, a large number of using biotechnology to realize industrial production process of the upgrading of the traditional technology and efficient. A new starting point, will and your business colleagues together, continuous efforts to improve human life and health.